Mode
Text Size
Log in / Sign up

JAK1 loss-of-function variants linked to Epidermodysplasia verruciformis and cutaneous HPV susceptibilityWhy Losing One Gene Causes Skin Cancer

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider JAK1 variants in genetic workup for Epidermodysplasia verruciformis with cutaneous HPV susceptibility.

This study was a genetic analysis with functional assays conducted in four unrelated pedigrees with Epidermodysplasia verruciformis (EV). The research aimed to identify the genetic basis for susceptibility to cutaneous HPV infection in this condition. The intervention or exposure studied was the presence of genetic variants in the JAK1 gene, with no specific comparator reported.

The main results identified five novel variants in JAK1 across the four pedigrees. Functional analysis demonstrated that three of these variants resulted in nonsense-mediated mRNA decay. Subsequent assays showed decreased phosphorylation of STATs, impaired interferon responses, and defective T cell activation. Patient immune profiling revealed reduced CD4/CD8 T cell ratios, decreased proportions of CD8 naive T cells, and accumulation of memory T cells. No quantitative effect sizes, absolute numbers, or statistical measures were reported for these findings.

Safety and tolerability data were not reported. The study was funded by multiple Chinese national science foundations and research programs, as well as an Italian regional grant. Key limitations include the absence of reported sample size, lack of clinical outcome data regarding HPV infection or non-melanoma skin cancer development, and the associative rather than causal nature of the findings. The practice relevance is not reported, but this research provides mechanistic insight into a potential genetic pathway involved in EV susceptibility to HPV.

Imagine your skin has a built-in security guard. This guard spots invaders and sounds the alarm. Now imagine that guard is broken. The invaders stay, multiply, and cause trouble. That is exactly what happens in a rare condition called Epidermodysplasia verruciformis, or EV. People with this condition get a very high number of skin cancers. But until now, doctors did not know exactly why their immune systems failed so badly.

Skin cancer is a huge problem worldwide. Most people get it from too much sun. But there is another kind called nonmelanoma skin cancer. This type is driven by Human papillomaviruses, or HPVs. These are viruses that usually cause warts or cervical cancer. In people with EV, these viruses attack the skin instead.

The condition is rare, but it is devastating. Patients develop hundreds of skin lesions. Many turn into cancer. Current treatments remove the spots. But they do not fix the root cause. The virus keeps coming back. Doctors need to understand the biology to find better ways to protect these patients.

The surprising shift

For years, scientists looked for many different gene errors. They found many. But the main reason remained a mystery. This new research changes that picture. It points to one specific gene called JAK1. When this gene works poorly, the body loses its ability to fight the virus.

Think of your immune system like a busy city. The virus is a thief trying to sneak into houses. Your immune cells are the police. They need a clear signal to chase the thief. That signal comes from a protein called STAT.

JAK1 is the messenger that delivers the signal. It acts like a switch. When the virus attacks, JAK1 flips the switch. This tells STAT to activate the police. But in people with EV, the JAK1 switch is broken. The signal never gets through. The police never show up. The thief stays in the house.

Researchers looked at four families. Each family had a member with EV. They tested the DNA of these patients. They found five different changes in the JAK1 gene. They also tested cells from patients and lab models. This showed how the broken gene stopped the immune response.

The study found that the broken JAK1 gene stops a key defense mechanism. Without it, the body cannot make enough interferon. Interferon is a chemical that tells cells to fight viruses. The study also showed that T cells, which are important immune soldiers, did not activate properly.

In simple terms, the body was confused. It could not tell the difference between a harmless cell and a virus-infected cell. The ratio of different immune cells was off. There were too many memory cells and too few fresh soldiers. This imbalance made it easy for the virus to take over.

But there's a catch. This discovery is huge for science. But it is not a magic bullet for patients yet.

Scientists say this confirms that losing JAK1 function causes the problem. It fits with what we know about how immunity works. This finding helps explain why some people get sick while others do not. It also opens doors for new treatments. Future drugs might target the JAK1 pathway to restore the signal.

If you have this rare condition, this news is hopeful. It means doctors now know the exact cause. If you are worried about skin cancer, talk to your doctor about sun safety. For most people, this research does not change daily life. But it helps researchers build better therapies for rare diseases.

This study looked at only four families. That is a small number. The findings are based on lab tests and patient samples. We do not know if this applies to everyone with similar symptoms. More research is needed to prove these results in larger groups.

Next steps include testing new drugs in the lab. Researchers want to see if fixing the JAK1 signal works. They also plan to study more patients. It will take time to turn this science into medicine. Approval processes are strict and necessary for safety.

Would you consider this if it becomes available?

SEO BOOST

  • Early symptoms of skin cancer
  • How the immune system fights viruses
  • Understanding rare genetic diseases

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Background: Human papillomaviruses (HPVs) pose a severe threat to global public health by driving nonmelanoma skin cancer (NMSC) and cervical cancer, with NMSC being one of the most common cancers worldwide. Epidermodysplasia verruciformis (EV) is an inborn error of immunity characterized by an increased susceptibility to persistent infection of cutaneous HPV and a high risk of NMSC. The genetic basis remains unknown in many patients with EV. Methods: We collected four unrelated pedigrees with EV. Genetic analysis identified five variants in JAK1 encoding the Janus kinase 1. Ex vivo models and patient-derived tissue were employed to evaluate the functional effects of JAK1 variants and delineate the pathogenic mechanisms. Results: We identified different variants in JAK1 in four pedigrees with dominant EV. Genetic analysis revealed five novel variants in JAK1, three of which resulted in nonsense-mediated mRNA decay (NMD). Functional assays identified a decreased phosphorylation of the signal transducers and activators of transcription (STATs), impaired interferon responses, and defective T cell activation. Immune dysregulation in patients, characterized by a reduced CD4/CD8 T cell ratio, decreased CD8 naive T cell proportion, and accumulated memory T cells, implies impaired antiviral immunity against HPV. Conclusions: Our findings confirm that JAK1 loss-of-function (LOF) variants underlie susceptibility to cutaneous HPV infection. [Funded by the National Natural Science Foundation of China (81788101, 81230015, 82394420, and 82394423), the National Key Research and Development Program of China (2022YFC2703900), the CAMS Innovation Fund for Medical Sciences (2021-I2M-1-018), and the Regione Lombardia, Italy (Innovative Research Project 1137-2010)].
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.